Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata
The expert panel discusses the secondary analysis from the phase 3 BRAVE clinical trials of baricitinib in alopecia areata.
EP: 1.Impact of Alopecia Areata on Quality of Life, and Current Standard of Treatment
EP: 2.JAK Inhibitor Baricitinib for Treatment of Alopecia Areata
Now Viewing
EP: 3.Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata
EP: 4.Novel Mechanisms of Action for Treatment of Alopecia Areata
EP: 5.Physician and Patient Communication for the Management of Alopecia Areata
Related Videos
Related Content
